個別化栄養: 世界市場 – BCC Research

Personalized Nutrition: Global Markets
個別化栄養: 世界市場

Report Highlights

The global personalized nutrition market reached $12.2 billion in 2022 and should reach $25.1 billion by 2028, with a compound annual growth rate (CAGR) of 12.5% during the forecast period of 2023-2028.

レポートのお問合せ

Report Synopsis

Report MetricsDetails
Base year considered2023
Forecast period considered2023-2028
Base year market size$13.9 billion
Market size forecast$25.1 billion
Growth rateCAGR of 12.5% for the forecast period of 2023-2028
Units considered$ Millions
Segments coveredComponent Type, Assessment Type, Supplement Type, Channel Type, Region
Regions coveredNorth America, Europe, Asia-Pacific, Rest of the World (RoW)
Countries coveredU.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, Russia, Sweden, Austria, Netherlands, Norway, China, India, Japan, South Korea, Australia, New Zealand, Malaysia, Indonesia, Taiwan, Singapore, South America, Middle East, Africa
Key Market Drivers
  • Growing Interest in Preventive Healthcare
  • Increasing Use of Advanced Technology
  • Growing Consumer Income Levels
  • Increase in Aging Population
Companies studiedAMWAY CORP. , ATLAS BIOMED GROUP LIMITED , BACTOLAC PHARMACEUTICAL INC. , BALCHEM CORP. , CUREFIT HEALTHCARE PRIVATE LIMITED , DAYTWO INC. , DNALYSIS BIOTECHNOLOGY , GENOPLAN INC. , HEALTHIFYME WELLNESS PRIVATE LIMITED , HERBALIFE NUTRITION LTD. , KONINKLIJKE DSM N.V. , MYGENOMEBOX CORP. , NOHO HEALTH INC. , NUTRIGENOMIX , PRENETICS EMEA LIMITED , VIOME LIFE SCIENCES INC. , ZIPONGO INC. , ZYWIE VENTURES PRIVATE LIMITED